Management and treatment of relapsed or refractory Ph(−) B-precursor ALL: A webbased, double-blind survey of EU clinicians
Số trang: 8
Loại file: pdf
Dung lượng: 445.41 KB
Lượt xem: 5
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
The prognosis for adult patients with Ph(-) B-precursor acute lymphoblastic leukaemia (ALL) who are refractory to treatment or experience relapse (R/R), is poor; over 90 % of these patients die from the disease, typically within a few months. While there are some national guidelines published for the treatment of adult patients with ALL, and local working group recommendations do exist, there is very little detail and no preferred treatment regimens for adult patients with R/R Ph(-) B-precursor ALL.
Nội dung trích xuất từ tài liệu:
Management and treatment of relapsed or refractory Ph(−) B-precursor ALL: A webbased, double-blind survey of EU clinicians
Nội dung trích xuất từ tài liệu:
Management and treatment of relapsed or refractory Ph(−) B-precursor ALL: A webbased, double-blind survey of EU clinicians
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Salvage therapy Treatment guidelines Experience relapse Adult patients B-precursor acute lymphoblastic leukaemiaTài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 171 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 142 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 120 0 0 -
12 trang 93 0 0
-
19 trang 74 0 0
-
17 trang 64 0 0
-
9 trang 43 0 0
-
13 trang 38 0 0
-
12 trang 38 0 0